Showing items 1481-1530 of 2308 (47 Page(s) Totally)
<< < 25 26 27 28 29 30 31 32 33 34 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2020-07-21T06:46:26Z |
Current advances of endobronchial ultrasonography in the diagnosis and staging of lung cancer
|
Lin S.-Y.; Yu C.-J.; CHAO-CHI HO; Lin C.-K.; Yang C.-Y.; Chang L.-Y. |
| 臺大學術典藏 |
2020-07-21T06:46:26Z |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis
|
Chen Y.-F.; Chang C.-H.; CHAO-CHI HO; Shih J.-Y.; Yu C.-J.; Yang J.C.-H.; Lee J.-H.; Lin C.-C.; Liao B.-C. |
| 臺大學術典藏 |
2020-07-21T06:46:26Z |
EGFR mutation and lobar location of lung adenocarcinoma
|
Tseng C.-H.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; CHAO-CHI HO; Hsia T.-C.; Su K.-Y.; Wu M.-F.; Chiu K.-L.; Liu C.-M.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; Chen K.-Y.; Liao W.-Y.; Shih J.-Y.; Yu S.-L.; Yu C.-J.; Yang P.-C.; Yang T.-Y.; Chang G.-C. |
| 臺大學術典藏 |
2020-07-21T06:46:25Z |
205P: Visualizing ZO-1-mediated coupled migration between cancer and stromal cells in lung cancer metastasis via a 5-dimensional cell imaging system
|
Chen H.-W.; CHAO-CHI HO; Yu C.-J.; Lu H.-H.; Chen B.-C. |
| 臺大學術典藏 |
2020-07-21T06:46:25Z |
151P: Outcomes of research biopsies in clinical trials of EGFR mutation-positive NSCLC patients pretreated with EGFR-TKIs
|
Chang Y.-C.; Yu C.-J.; Yang J.; Shih J.-Y.; CHAO-CHI HO; Liao B.-C.; Bai Y.-Y.; Lin C.-C.; Lin S.-Y.; Lee Y.-F. |
| 臺大學術典藏 |
2020-07-21T06:46:25Z |
Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis
|
Chen L.-Y.; Molina-Vila M.A.; Ruan S.-Y.; Su K.-Y.; Liao W.-Y.; Yu K.-L.; CHAO-CHI HO; Shih J.-Y.; Yu C.-J.; Yang J.C.H.; Rosell R.; Yang P.-C. |
| 臺大學術典藏 |
2020-07-21T06:46:25Z |
Prospective evaluation of procalcitonin, soluble triggering receptor expressed on myeloid cells-1 and c-reactive protein in febrile patients with autoimmune diseases
|
Lin C.-H.; Hsieh S.-C.; Keng L.-T.; Lee H.-S.; Chang H.-T.; Liao W.-Y.; CHAO-CHI HO; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:46:24Z |
EGFR mutation, smoking, and gender in advanced lung adenocarcinoma
|
Tseng C.-H.; Chiang C.-J.; Tseng J.-S.; Yang T.-Y.; Hsu K.-H.; Chen K.-C.; Wang C.-L.; Chen C.-Y.; Yen S.H.; Tsai C.-M.; Huang M.-S.; CHAO-CHI HO; Yu C.-J.; Tsai Y.-H.; Chen J.-S.; Chou T.-Y.; Tsai M.-H.; Chen H.-Y.; Su K.-Y.; Chen J.J.W.; Chen H.-W.; Yu S.-L.; Liu T.-W.; Chang G.-C. |
| 臺大學術典藏 |
2020-07-21T06:46:24Z |
Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patients
|
Chen J.J.W.; Chang G.-C.; Yang P.-C.; Liu C.-M.; Chiu K.-L.; Wu M.-F.; Hsia T.-C.; CHAO-CHI HO; Yu C.-J.; Tseng C.-H.; Chen H.-Y.; Chen K.-C.; Tsai C.-R.; Yang C.-T.; Yu S.-L.; Su K.-Y.; Yang T.-Y.; Wang C.-L.; Hsu K.-H.; Tseng J.-S. |
| 臺大學術典藏 |
2020-07-21T06:46:23Z |
Expression of notch gene and its impact on survival of patients with resectable non-small cell lung cancer
|
Hsieh M.-S.; CHAO-CHI HO; Chen K.-Y.; Shih J.-Y.; Yu C.-J.; Chen C.-Y.; Chen Y.-Y. |
| 臺大學術典藏 |
2020-07-21T06:46:23Z |
Outcomes of cancer therapy administered to treatment-na?ve lung cancer patients in the intensive care unit
|
Chen Y.-F.; Lin J.-W.; CHAO-CHI HO; Yang C.-Y.; Chang C.-H.; Huang T.-M.; Chen C.-Y.; Chen K.-Y.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:46:22Z |
Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib
|
Yang J.C.H.; Yu C.-J.; Lin C.-C.; Yao Z.-H.; Lin Z.-Z.; Chen J.-S.; Liao W.-Y.; CHAO-CHI HO; Chen K.-Y.; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:46:22Z |
Experience improves the performance of endobronchial ultrasound-guided transbronchial biopsy for peripheral pulmonary lesions: A learning curve at a medical centre
|
Yu C.-J.; Huang C.-T.; Ruan S.-Y.; Tsai Y.-J.; CHAO-CHI HO |
| 臺大學術典藏 |
2020-07-21T06:46:22Z |
Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib
|
CHAO-CHI HO; Liao W.-Y.; Lin C.-A.; Shih J.-Y.; Yu C.-J.; Chih-Hsin Yang J. |
| 臺大學術典藏 |
2020-07-21T06:46:21Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin C.-C.; Lee J.-H.; Chang Y.-L.; Su K.-Y.; Hsu W.-H.; Hsu C.-L.; Tsai T.-H.; Chen K.-Y.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; CHAO-CHI HO; Liao W.-Y.; Yu C.-J.; Yang J.C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:46:21Z |
The value of repeat radial-probe endobronchial ultrasound-guided transbronchial biopsy after initial non-diagnostic results in patients with peripheral pulmonary lesions
|
Yu C.-J.; Tsai Y.-J.; CHAO-CHI HO; Huang C.-T. |
| 臺大學術典藏 |
2020-07-21T06:46:21Z |
Astrocyte-elevated gene-1 confers resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase expression
|
Yang P.-C.; Yu C.-J.; Chen C.-Y.; Chen Y.-Y.; Chen J.J.W.; Chen K.-Y.; CHAO-CHI HO; Shih J.-Y.; Chang Y.-L. |
| 臺大學術典藏 |
2020-07-21T06:46:20Z |
Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery
|
Yu C.-J.; Yang J.C.-H.; Kuo S.-H.; Cheng J.C.-H.; Yang P.-C.; Hsu F.-M.; Liao W.-Y.; Chen K.-Y.; Tseng H.-M.; Chen Y.-F.; CHAO-CHI HO; Shih J.-Y.; Xiao F.; Yang W.-C. |
| 臺大學術典藏 |
2020-07-21T06:46:19Z |
Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum
|
Liao W.-Y.; CHAO-CHI HO; Tsai T.-H.; Chen K.-Y.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:46:19Z |
Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors
|
Liao B.-C.; Bai Y.-Y.; Lee J.-H.; Lin C.-C.; Lin S.-Y.; Lee Y.-F.; CHAO-CHI HO; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Chih-Hsin Yang J.; Yang P.-C. |
| 臺大學術典藏 |
2020-07-21T06:46:19Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Yu C.-J.; CHAO-CHI HO; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H.; Lin C.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:46:18Z |
Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non–Small-cell Lung Cancer Patients
|
Wu T.-H.; Hsiue E.H.-C.; Lee J.-H.; Lin C.-C.; Liao W.-Y.; CHAO-CHI HO; Shih J.-Y.; Yu C.-J.; Yang J.C.-H. |
| 臺大學術典藏 |
2020-07-21T06:46:17Z |
EGFR-Mutant SCLC Exhibits Heterogeneous Phenotypes and Resistance to Common Antineoplastic Drugs
|
Lin C.-A.; Yu S.-L.; Chen H.-Y.; Chen H.-W.; Lin S.-U.; Chang C.-C.; Yu C.-J.; Yang P.-C.; CHAO-CHI HO |
| 臺大學術典藏 |
2020-07-21T06:46:16Z |
Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients
|
Yao Z.-H.; Liao W.-Y.; CHAO-CHI HO; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:46:16Z |
Atypical cells in pathology of endobronchial ultrasound-guided transbronchial biopsy of peripheral pulmonary lesions: incidence and clinical significance
|
Huang C.-T.; Tsai Y.-J.; CHAO-CHI HO; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:46:16Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Lin Y.-T.; Chen J.-S.; Liao W.-Y.; CHAO-CHI HO; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; Lee J.-H.; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:46:15Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.; Chang Y.-L.; Su K.-Y.; Hsu C.-L.; Liu Y.-N.; Chen K.-Y.; Tsai T.-H.; Liao W.-Y.; CHAO-CHI HO; Yang C.-Y. |
| 臺大學術典藏 |
2020-07-21T06:46:15Z |
Radial endobronchial ultrasound-guided transbronchial biopsy for peripheral pulmonary malignancy: Biopsy- or brushing-first?
|
Huang C.-T.; Tsai Y.-J.; CHAO-CHI HO; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:46:14Z |
Nivolumab safety and efficacy in advanced, platinum-resistant, non-small cell lung cancer, radical radiotherapy-ineligible patients: A phase II study in Taiwan
|
Chen Y.-M.; Chih-Hsin Yang J.; Su W.-C.; Chong I.-W.; Hsia T.-C.; Lin M.-C.; Chang G.-C.; Chiu C.-H.; CHAO-CHI HO; Wu S.-Y.; Hung J.-Y.; Wang C.-C.; Yang T.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:25:19Z |
RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer
|
TZU-HSIU TSAI; Su K.-Y.; Wu S.-G.; Chang Y.-L.; Luo S.-C.; Jane I.-S.; Yu C.-J.; Yue S.-L.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-07-21T06:25:19Z |
Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma
|
Yang P.-C.; Shih J.-Y.; Yu C.-J.; Yang C.-H.; TZU-HSIU TSAI; Wu S.-G.; Chang Y.-L.; Wu C.-T.; Tsai M.-F.; Wei P.-F. |
| 臺大學術典藏 |
2020-07-21T06:25:18Z |
Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations
|
Chen Y.-F.;Hsieh M.-S.;Wu S.-G.;Chang Y.-L.;Shih J.-Y.;Liu Y.-N.;Tsai M.-F.;Tzu-Hsiu Tsai;Yu C.-J.;Yang J.C.-H.;Yang P.-C.; Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; TZU-HSIU TSAI; Yu C.-J.; Yang J.C.-H.; Yang P.-C. |
| 臺大學術典藏 |
2020-07-21T06:25:18Z |
Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy
|
Yang P.-C.; Shih J.-Y.; Yang J.C.H.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Jan I.-S.; Chen K.-Y.; Wang J.-Y.; Ruan S.-Y.; Yang C.-Y.; TZU-HSIU TSAI |
| 臺大學術典藏 |
2020-07-21T06:25:17Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Yang J.C.-H.; Thress K.S.; Huang D.D.-R.; Lin C.-C.;Shih J.-Y.;Yu C.-J.;Ho C.-C.;Liao W.-Y.;Lee J.-H.;Tzu-Hsiu Tsai;Su K.-Y.;Hsieh M.-S.;Chang Y.-L.;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Lee J.-H.; TZU-HSIU TSAI; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y. |
| 臺大學術典藏 |
2020-07-21T06:25:17Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Liao W.-Y.; Ho C.-C.; Liao B.-C.; Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Ho C.-C.;Liao W.-Y.;Chen K.-Y.;Tzu-Hsiu Tsai;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Chang Y.-L.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Yang J.C.; Yu C.-J.; Shih J.-Y.; Lin C.-C.; Lee J.-H.; Chang Y.-L.; Su K.-Y.; Hsu W.-H.; Hsu C.-L.; TZU-HSIU TSAI; Chen K.-Y. |
| 臺大學術典藏 |
2020-07-21T06:25:17Z |
Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion
|
Tzu-Hsiu Tsai;Wu S.-G.;Hsieh M.-S.;Yu C.-J.;Yang J.C.H.;Shih J.-Y.; TZU-HSIU TSAI; Wu S.-G.; Hsieh M.-S.; Yu C.-J.; Yang J.C.H.; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:25:16Z |
Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum
|
Liao W.-Y.;Ho C.-C.;Tzu-Hsiu Tsai;Chen K.-Y.;Shih J.-Y.;Yu C.-J.; Liao W.-Y.; Ho C.-C.; TZU-HSIU TSAI; Chen K.-Y.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:25:15Z |
Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors
|
Shih J.-Y.; Liao W.-Y.; Lee J.-H.;Chen H.-Y.;Hsu F.-M.;Chen J.-S.;Liao W.-Y.;Shih J.-Y.;Yu C.-J.;Chen K.-Y.;Tzu-Hsiu Tsai;Yang J.C.-H.; Lee J.-H.; Chen H.-Y.; Hsu F.-M.; Chen J.-S.; Yang J.C.-H.; Yu C.-J.; Chen K.-Y.; TZU-HSIU TSAI |
| 臺大學術典藏 |
2020-07-21T06:25:14Z |
Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer
|
TZU-HSIU TSAI; Wu S.-G.; Liu Y.-N.; Yu C.-J.; Shih J.-Y.; Lin Y.-T.; Lin Y.-T.;Tzu-Hsiu Tsai;Wu S.-G.;Liu Y.-N.;Yu C.-J.;Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:09:16Z |
Symptoms, psychological distress, and supportive care needs in lung cancer patients
|
Liao Y.-C.; WEI-YU LIAO; Shun S.-C.; Yu C.-J.; Yang P.-C.; Lai Y.-H.; Liao Y.-C.;Wei-Yu Liao;Shun S.-C.;Yu C.-J.;Yang P.-C.;Lai Y.-H. |
| 臺大學術典藏 |
2020-07-21T06:09:15Z |
Risk Factors of Pneumothorax after Endobronchial Ultrasound-Guided Transbronchial Biopsy for Peripheral Lung Lesions
|
Huang C.-T.; Ruan S.-Y.; WEI-YU LIAO; Kuo Y.-W.; Lin C.-Y.; Tsai Y.-J.; Ho C.-C.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:09:14Z |
Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy
|
Tsai T.-H.;Yang C.-Y.;Ho C.-C.;Wei-Yu Liao;Jan I.-S.;Chen K.-Y.;Wang J.-Y.;Ruan S.-Y.;Yu C.-J.;Yang J.C.H.;Yang P.-C.;Shih J.-Y.; Tsai T.-H.; Yang C.-Y.; Ho C.-C.; WEI-YU LIAO; Jan I.-S.; Chen K.-Y.; Wang J.-Y.; Ruan S.-Y.; Yu C.-J.; Yang J.C.H.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:09:14Z |
Anxiety, depression and related factors in family caregivers of newly diagnosed lung cancer patients before first treatment
|
Lee Y.-H.;Liao Y.-C.;Wei-Yu Liao;Shun S.-C.;Liu Y.-C.;Chan J.-C.;Yu C.-J.;Yang P.-C.;Lai Y.-H.; Lee Y.-H.; Liao Y.-C.; WEI-YU LIAO; Shun S.-C.; Liu Y.-C.; Chan J.-C.; Yu C.-J.; Yang P.-C.; Lai Y.-H. |
| 臺大學術典藏 |
2020-07-21T06:09:14Z |
Survival of lung adenocarcinoma patients with malignant pleural effusion
|
Wu S.-G.;Yu C.-J.;Tsai M.-F.;Wei-Yu Liao;Yang C.-H.;Jan I.-S.;Yang P.-C.;Shih J.-Y.; Wu S.-G.; Yu C.-J.; Tsai M.-F.; WEI-YU LIAO; Yang C.-H.; Jan I.-S.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:09:14Z |
Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer
|
Wei-Yu Liao;Chen J.-H.;Wu M.;Shih J.-Y.;Chen K.-Y.;Ho C.-C.;Yang J.C.-H.;Yu C.-J.; WEI-YU LIAO; Chen J.-H.; Wu M.; Shih J.-Y.; Chen K.-Y.; Ho C.-C.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:09:13Z |
Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer
|
Yang J.C.-H.; Chang Y.-C.; Yu C.-J.; Shih J.-Y.; Lin C.-C.; Chen K.-Y.; Ho C.-C.; WEI-YU LIAO; Yang P.-C.; Chen H.-Y.; Hsu W.-H.; Lin Y.-L.; Lee J.-H.; Lee J.-H.;Lin Y.-L.;Hsu W.-H.;Chen H.-Y.;Chang Y.-C.;Yu C.-J.;Shih J.-Y.;Lin C.-C.;Chen K.-Y.;Ho C.-C.;Wei-Yu Liao;Yang P.-C.;Yang J.C.-H. |
| 臺大學術典藏 |
2020-07-21T06:09:13Z |
Quality of life and related factors in patients with newly diagnosed advanced lung cancer: A longitudinal study
|
Liao Y.-C.; Shun S.-C.; WEI-YU LIAO; Yu C.-J.; Yang P.-C.; Lai Y.-H. |
| 臺大學術典藏 |
2020-07-21T06:09:12Z |
Heparin co-factor II enhances cell motility and promotes metastasis in non-small cell lung cancer
|
Yang P.-C.; Lee C.-H.; Yu C.-J.; Hou H.-H.; Hsu T.-H.; Tsai M.-F.; Chen K.-Y.; Chen H.-Y.; Lee Y.-C.; Ho C.-C.; WEI-YU LIAO |
| 臺大學術典藏 |
2020-07-21T06:09:12Z |
GM2-activator protein: A new biomarker for lung cancer
|
Potprommanee L.; Ma H.-T.; Shank L.; Juan Y.-H.; WEI-YU LIAO; Chen S.-T.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:09:11Z |
EGFR mutation and lobar location of lung adenocarcinoma
|
Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; Chen K.-Y.; WEI-YU LIAO; Shih J.-Y.; Yu S.-L.; Yu C.-J.; Yang P.-C.; Yang T.-Y.; Chang G.-C.; Chen H.-J.; Wu T.-C.; Tseng C.-H.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Ho C.-C.; Hsia T.-C.; Su K.-Y.; Wu M.-F.; Chiu K.-L.; Liu C.-M. |
Showing items 1481-1530 of 2308 (47 Page(s) Totally)
<< < 25 26 27 28 29 30 31 32 33 34 > >>
View [10|25|50] records per page
